ArticleBMJ open2022

Cost-effectiveness of GeneXpert Omni compared with GeneXpert MTB/Rif for point-of-care diagnosis of tuberculosis in a low-resource, high-burden setting in Eastern Uganda: a cost-effectiveness analysis based on decision analytical modelling.

David Livingstone Ejalu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.